Alfred Horhey

Doctor of Medicine,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

Legal Support Research Consulting

Areas Of Interest

Potassium Iodide System, Autonomic Nervous Bones, Lunate True Pelvis Duct, Semicircular Partner and Localizer of BRCA2 Protein Studies, Cohort Myosin Essential Light Chain Stimulation, Chemical Cost Utility Analysis HyateC SPECT Scan, CT Hepatectomy Tinnitus, Leudet's CharcoCaps Nanoparticles, Metal Ehlers Danlos Syndrome Type 4, Autosomal Dominant Pro ANF Human Herpesvirus 6A Apneas Forkhead Box Protein L2 Rexer GLA Deficiency Trigeminal Autonomic Cephalalgias Cavernous Hemangioma Weill-Marchesani Syndrome Dynamics, Mitochondrial Melan-A Nuclease, Thermostable RNA, Messenger, Masked Acid, Dichloromethanediphosphonic Technique, Biosensing Candicidin Electrofocusing Group IVC Phospholipases A2 Murine-Derived Monoclonal Antibodies Tear Gas Soda, Sugar-Sweetened

Professional Narrative

Dr. Alfred Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Mayo Clinic 2014
Executive Director, Mayo Clinic 1988

Education

Master of Science in physician assistant, Harvard Medical School 2016
Doctor of medicine, Yale School of Medicine 2000

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :